GSDMD and non-small cell lung carcinoma: In summary, pyroptosis-related molecules GSDMD and CASP1/4/5 were highly expressed in PBMCs of patients with NSCLC, and their expression levels were closely related to the clinical features of patients, and might be potential molecular markers for early diagnosis and evaluation the severity of this disease.